Posted by Michael Wonder on 22 Jun 2017
Trump plan aims to be pro-pharma and cut drug prices
22 June 2017 - Facing opposition and delay to healthcare reform in Congress, Trump aims to pass an executive order to address drug pricing – but it contains the now familiar contradictions
Donald Trump is understood to be preparing an executive order to tackle drug prices – but leaked details suggest it is far more pharma friendly than originally thought.
The rumours have led to a major rally in pharma shares, and the biotech index has had its best three day performance since Trump won the election in November.
